top of page

Publications

Medical and social rehabilitation of patients operated on for cancer of the distal part of the stomach / V.G. Bondar, B.A. Bogdanov, Y.V. Ostapenko // International Medical Journal. - 2002. - No. 3. P. 105-107.

Radionuclide assessment of motor-evacuator function of the gastric stump in patients operated on for distal cancer / V.G. Bondar, N.V. Tanasychuk-Gazhieva, Y.V. Ostapenko, B.A. Bogdanov, Y.V. Kuzmenko // Ukrainian Radiological Journal. – 2003. – No. 2. – P.152-153.

Distal resection in malignant and chronic gastric ulcer / V.G. Bondar, B.A. Bogdanov, Y.V. Ostapenko, O.M. Zaika, G.V. Bondar // Surgery of Ukraine. - 2004. - No. 2 (10). - P.54-57.

Pat. 15380 Ukraine, MPK A61V 17/00. Method of complex treatment of breast cancer / Ya. V. Denysenko, Yu. V. Ostapenko, I. E. Sedakov, O. I. Oleksandrov. – appl. 29.03.2006, publ. – 15.06.2006, bull. №6. – 2 p.

Symptomatic surgery of unresectable distal gastric cancer / Yu. A. Saliyev, Yu. V. Ostapenko // Neoplasms. - 2007. - No. 1. - P.83-87.

Annals of Oncology. Volume 28 | Supplement 3 | June 2017

P-228 Surgical treatment of pancreatic tumors in children

Y. Ostapenko, O. Kolesnyk, A. Lukashenko,

National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 28 | Supplement 3 | June 2017

P-129 Multivisceral resections of T4 gastric cancer
O. Kolesnyk, A. Lukashenko, N. Chorna, Y. Ostapenko
National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 28 | Supplement 3 | June 2017

P -090 Neoadjuvant chemotherapy for gastric cancer: evaluation of efficacy

O. Kolesnyk, A. Lukashenko, N. Chorna, Y. Ostapenko

National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 28 | Supplement 3 | June 2017

P-351 Simultaneous and staged resections in patients with synchronous

colorectal metastases to the liver
O. Kolesnyk, A. Lukashenko, N. Chorna, Y. Ostapenko
National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 29 | Supplement 5 | June 2018

P-290 Simultaneous and staged resection of liver metastases

in patients with advanced colorectal cancer
O. Kolesnyk, A. Lukashenko, Y. Ostapenko, N. Chorna
National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 29 | Supplement 5 | June 2018

P-092 Multivisceral resections for locally advanced gastric cancer

Y. Ostapenko, A. Lukashenko, O. Kolesnyk, N. Chorna, A. Boyko
National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 29 | Supplement 5 | June 2018

R-179 Surgical treatment of pancreatic tumors in children
A. Lukashenko, Y. Ostapenko, O. Kolesnyk, N. Chorna
National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 29 | Supplement 5 | June 2018

P-077 Benefits of neoadjuvant chemotherapy in resectable gastric cancer

N. Chorna, A. Lukashenko, Y. Ostapenko, O. Kolesnyk, A. Boyko

National Cancer Institute of Ukraine, Kyiv, Ukraine

European Journal of Surgical Oncology. Volume45| Supplement 2 | February 2019

Efficacy of percutaneous transhepatic cholangiostomy in the treatment of mechanical jaundice

M. Zubarev, O. Kolesnyk, A. Lukashenko, A. Boyko, Y. Ostapenko

National Cancer Institute, Kyiv, Ukraine

Annals of Oncology. Volume 30 | Supplement 4 July 2019

P-358 Simultaneous lung and liver resections in patients with metastatic colorectal cancer

A. Lukashenko, O. Kolesnyk, N. Chorna, Y. Ostapenko, V. Patsko

National Cancer Institute, Kyiv, Ukraine

Annals of Oncology. Volume 30 | Supplement 4 July 2019

P-359 Synchronous resection of neuroendocrine tumors with synchronous liver metastases (SNTLM)

O. Kolesnyk, A. Lukashenko, Y. Ostapenko, N. Chorna, V. Patsko

National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 30 | Supplement 4 July 2019

P-360 Neuroendocrine tumors of the pancreas
O. Kolesnyk, A. Lukashenko, N. Chorna, Y. Ostapenko, V. Patsko
National Cancer Institute of Ukraine, Kyiv, Ukraine.

Annals of Oncology. Volume 30 | Supplement 4 July 2019

P-361 Laparoscopic liver resection for metastatic colorectal cancer
O. Kolesnyk, A. Lukashenko, Y. Ostapenko, N. Chorna, V. Patsko
National Cancer Institute, Kyiv, Ukraine.

An American Society of Clinical Oncology journal. Volume 39, Supplement 15|May 2021

Phase 2 study of the PD-1 inhibitor JTX-4014 alone and in combination with the ICOS agonist vopratelimab,

in subjects with selected biomarkers with metastatic NSCLC after one prior regimen

platinum drug treatment (SELECT)

O. Kobziyev, I. Bulat, Y. Ostapenko, Z. Zvirbule, G. Ursol

An American Society of Clinical Oncology journal. Volume 40|Supplement 16|June 2022

Results of the phase 3 HIMALAYA study of tremelimumab and durvalumab, which

reported by patients with inoperable hepatocellular carcinoma

B. Sangro, P. R. Halle, R. K. Kelly, C. Charoentum, Y. Ostapenko

An American Society of Clinical Oncology journal. Volume 40|Supplement 16|June 2022

Evaluation of the effectiveness of neoadjuvant chemotherapy in patients with resectable gastric cancer
V. Patsko, A. Lukashenko, Y. Ostapenko
National Cancer Institute, Kyiv, Ukraine.

The New England Journal of Medicine. Volume 1|Supplement 8|June 2022

Tremelimumab plus Durvalumab for inoperable hepatocellular carcinoma

G. K. Abu-Alfa, MD, MBA, G. Lau, Yu. Ostapenko

American Association for Cancer Research. Volume 82|Supplement 12|June 2022

Abstract CT551: A randomized phase III study comparing efficacy and safety

CT-P16, a new biosimilar, with reference bevacizumab (Avastin®) in patients with metastatic

or recurrent non-small cell lung cancer (NSCLC).
Y. Oge, I. Bondarenko, Z. Andrych, Y. Ostapenko, T. Chulianu

Annals of Oncology. Volume 34 | Supplement 1|S92-S93|June 2023

P-216 Surgical safety and oncological outcomes of laparoscopic liver resection in

colorectal liver cancer metastases at the Ukrainian State Center
V. Rozhkova, A. Lukashenko, A. Burlaka, Y. Ostapenko, A. Rudskoy
National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 34 | Supplement 1| S39|June 2023

P-71 Overcoming chemoresistance in patients with metastatic colorectal cancer

via hepatic artery infusion

K. Cherchenko, A. Lukashenko, Yu. Ostapenko, V. Patsko, M. Vinogradova

National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 34 | Supplement 1|S168| June 2023

SO-15 Update on four-year overall survival from the study results

HIMALAYA Phase 3 trial of tremelimumab and durvalumab in unresectable hepatocellular carcinoma

B. Sangro, S. Chan, R. Kelly, G. Lau, Y. Ostapenko

National Cancer Institute of Ukraine, Kyiv, Ukraine

An American Society of Clinical Oncology journal. Volume 41|Supplement 16| May 2023

Intraarterial chemotherapy of colorectal cancer metastases in the liver

V. Patsko, A. Lukashenko, Yu. Ostapenko

National Cancer Institute of Ukraine, Kyiv, Ukraine

Annals of Oncology. Volume 34 | Supplement 4|S1530-S1531| November 2023

147P Update on four-year overall survival (OS) from a phase III study

HIMALAYA tremelimumab and durvalumab in unresectable hepatocellular carcinoma (uHCC)
S.L. Chan, B. Sangro, R.K. Kelly, G. Lau, Y. Ostapenko

European Journal of Surgical Oncology. Volume 50 | Supplement 2|107890| February 2024

Localized endometrioid-associated clear cell carcinoma of the anterior abdominal wall: a case report

K. Cherchenko, Yu. Ostapenko, A. Lukashenko, A. Shtoda, M. Vinogradova

National Cancer Institute of Ukraine, Kyiv, Ukraine

European Journal of Surgical Oncology. Volume 50 | Supplement 2| 107630| February 2024

Experience with placing an arterial catheter and port for hepatic arterial infusion

via laparotomy surgery: a single-center study

K. Cherchenko, Y. Ostapenko, A. Lukashenko, V. Patsko, M. Vinohradova

National Cancer Institute of Ukraine, Kiev, Ukraine

The New England Journal of Medicine. Volume 1|Supplement 8|June 2024
Amivantamab plus lazertinib for previously untreated EGFR-mutated NSCLC
Byoung C. Cho, MD, Ph.D., Shun Lu, Y. Ostapenko

bottom of page